PHGE - BiomX Inc.
Close
0.7081
0 0%
Share volume: 200
Last Updated: Wed 08 Jan 2025 04:43:36 PM CET
Research and Development in Biotechnology (except Nanobiotechnology):
-0.38%
PREVIOUS CLOSE
CHG
CHG%
$0.71
0.00
0.00%
Summary score
18%
Profitability
22%
Dept financing
16%
Liquidity
15%
Performance
15%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 2020 - 2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-8.44%
Return on assets
3.68%
Return on sales
0%
Return on invested capital
-183.18%
Total debt ratio
37.01%
Debt ratio change over timeo
-1.2%
Current Ratio
20.52%
Quick Ratio
0%
Cash Position Ratio
17.3%
Short-term ratios 2023 - 2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
15.52%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
67.9%
Debt ratio change over timeo
-1.37%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Last quarter ratios 2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
15.52%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
67.9%
Debt ratio change over time
-1.37%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Performance ratios (change over 4 years) 2020 - 2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-95.41%
Return on assets
-102.02%
Return on sales
0%
Return on invested capital
-0.48%
Total debt ratio
-120.2%
Debt ratio change over time
-1.2%
Current Ratio
-12.15%
Quick Ratio
0%
Cash Position Ratio
-10.4%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
Long-term ratios | PHGE | ABBV | AMGN | VRTX |
---|---|---|---|---|
Return on equity | -8.44% | 13.03% | 18.15% | 6.63% |
Return on assets | 3.68% | 2.28% | 3.22% | 5.84% |
Return on sales | 0% | 27.95% | 31.46% | 43.41% |
Return on invested capital | -183.18% | 2.07% | 5.53% | 34.89% |
Profitability | 16% | 45% | 61% | 84% |
Total debt ratio | 37.01% | 91.02% | 90.77% | 24.67% |
Debt ratio change over time | -1.2% | 435.59% | 17.23% | -0.06% |
Dept financing | 10% | 50% | 26% | 7% |
Current Ratio | 0% | 0.82% | 1.41% | 3.64% |
Quick Ratio | 0% | 0.71% | 0.99% | 3.42% |
Cash Position Ratio | 0% | 0.31% | 0.49% | 2.77% |
Liquididy | 50% | 6% | 13% | 35% |
Short-term ratios | PHGE | ABBV | AMGN | VRTX |
---|---|---|---|---|
Return on equity | 0% | 0% | 0% | 5.91% |
Return on assets | 15.52% | 1.6% | 2.14% | 4.97% |
Return on sales | 0% | 24.8% | 18.91% | 42.59% |
Return on invested capital | 0% | 0% | 0% | 23.7% |
Profitability | 25% | 17% | 15% | 83% |
Total debt ratio | 67.9% | 94.49% | 93.35% | 24.56% |
Debt ratio change over time | -1.37% | 0% | 0% | -0.62% |
Dept financing | 18% | 25% | 50% | 6% |
Current Ratio | 0% | 0.82% | 1.41% | 3.64% |
Quick Ratio | 0% | 0.71% | 0.99% | 3.42% |
Cash Position Ratio | 0% | 0.31% | 0.49% | 2.77% |
Liquididy | 0% | 14% | 21% | 75% |